Interactions between brain, psyche and thyroid;Interaktionen zwischen gehirn, psyche und schilddrüse

NuklearMedizin

Volumn 47, Issue 6, 2008, Pages 225-234

  Schmidt, Matthias ^a   Huff, W ^a   Dietlein, M ^a   Kobe, C ^a   Schicha, H ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Brain; Depression; Hyperthyroidism; Hypothyroidism; Psyche

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

BRAIN; COGNITIVE DEFECT; DEPRESSION; HYPERTHYROIDISM; HYPOTHYROIDISM; MENTAL PERFORMANCE; MOOD; MOTIVATION; REVIEW; THYROID GLAND;

COGNITION; DEPRESSION; HUMANS; HYPERTHYROIDISM; LIBIDO; MENTAL RETARDATION; PANIC DISORDER; RISK FACTORS; THYROIDECTOMY; THYROXINE;

EID: 57349162115     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0191     Document Type: Review

References (97)

1. Abalovich M, Amino N, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007; 92 [8, Suppl]: S1-S47.
2. Altshuler LL, Bauer M, Frye MA et al. Does thyroid supplementation accelerate tricyclic antidepressant response ? A review and meta-analysis of the literature. Am J Psychiatry 2001; 158: 1617-1622.
3. Álvarez-Pedrerol M, Ribas-Fitó N, Torrent M et al. TSH concentrations within the normal range is associated with cognitive function and ADHD symptoms in healthy preschoolers. Clin Endocrinol 2007; 66: 890-898.
4. Aronson R, Offman HJ, Joffe RT et al. Triiodothyronine augmentation in the treatment of refractory depression. Arch Gen Psychiatry 1996; 53: 842-848.
5. Attia J, Margetts P, Guyatt G. Diagnosis of thyroid disease in hospitalized patients: a systematic review. Arch Intern Med 1999; 159: 658-665.
6. Bartalena L, Pellegrini L, Meschi M et al. Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorders. Psychiatry Res 1990; 34: 13-17.
7. Bauer M, Heinz A, Whybrow PC. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry. 2002; 7: 140-156.
8. Bauer M, Whybrow P, Angst J et al. WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders. World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002b; 1: 5-43.
9. Baumgartner A. Schilddrüsenhormone und depressive Erkrankungen-Kritische Übersicht und Perspektiven. Teil I: Klinik. Nervenarzt 1993; 64: 1-10.
10. Bernal J. Thyroid hormone receptors in brain development and function. Nature Clin Pract Endocrinol Metab 2007; 3: 249-259.
11. Bjerke SN, Bjoro T, Heyerdahl S. Psychiatric and cognitive aspects of hypothyroidism. Tidsskr Nor Laegeforen 2001; 121: 2373-2376.
12. Bocchetta A, Bernardi F, Pedditzi M et al. Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand 1991; 83: 193-198.
13. Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Mental Health 2006; 2: 1-5.
14. Bono G, Fancellu R, Blandini F et al. Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment. Acta Neurol Scand 2004 ; 110: 59-66.
15. Brabant G, Kahaly GJ, Schicha H et al. Milde Formen der Schilddrüsenfehlfunktion. Ursachen, Diagnostik, Vorgehen. Dtsch Ärztebl 2006; 103: A2110-A2115.
16. Brent GA. Diagnosing thyroid dysfunction in pregnant women: is case finding enough ? J Clin Endocrinol Metab 2007; 92: 39-41.
17. Brownlie BEW, Rae AM, Walshe JWB et al. Psychoses associated with thyrotoxicosis-"thyrotoxic psychosis". A report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol 2000; 142: 438-444.
18. Chueire VB, Romaldini JH, Ward LS. Subclinical hypothyroidism increases the risk for depression in the elderly. Arch Gerontol Geriatr 2007; 44: 21-28.
19. Chueire VB, Silva ETB, Perotta E et al. High serum TSH levels are associated with depression in the elderly. Arch Gerontol Geriatr 2003; 36: 281-288.
20. Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol 2007; 32: 49-65.
21. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (Hrsg). Behandlungsleitlinie affektive Errkrankungen. Reihe: Praxisleitlinien in Psychiatrie und Psychotherapie. Band 5. Steinkopff: Darmstadt 2000.
22. Dietlein M, Dederichs B, Kobe C et al. Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery. Nuklearmedizin 2006; 45: 21-34.
23. Dietlein M, Kahaly G, Kobe C et al. Adipositas, Stoffwechsel und Schilddrüse. Ist der grenzwertig hohe TSH-Spiegel Ursache oder Sekundärphänomen der Adipositas? Nuklearmedizin 2008; 47: 181-187.
24. Dietlein M, Wegscheider K, Vaupel R et al. Management of multinodular goiter in Germany (Papillon 2005): Do the approaches of thyroid specialists and primary care practitioners differ? Nuklearmedizin 2007; 46: 65-75
25. Dratman MB, Futaesaku Y, Crutchfield FL et al. Iosine-125-labeled triiodothyronine in rat brain: evidence for localization in discrete neuronal systems. Science 1982; 215: 309-312.
26. Dunkelmann S, Künstner H, Nabavi E et al. Lithium as an adjunct to radioiodine therapy in Graves' disease for prolonging the intrathyroidal effective half-life of radioiodine. Useful or not? Nuklearmedizin 2006; 45: 213-218.
27. Duval F, Mokrani M-C, Ortiz JAM et al. Neuroendocrine predictors of the evolution of depression. Dialogues Clin Neurosci 2005; 7: 273-282.
28. Easson WM. Myxedema psychosis-insanity defense in homicide. J Clin Psychiatry 1980; 41: 316-318.
29. Engum A, Bjoro T, Mykletun A et al. Thyroid autoimmunity, depression and anxiety; are there any connections ? An epidemiological study of a large population. J Psychosomatic Res 2005; 59: 263-268.
30. Forman-Hoffamn V, Philibert RA. Lower TSH and higher T4 levels are associated with current depressive syndromes in young adults. Acta Psychiatr Scand 2005; 114: 132-139.
31. Fountoulakis KN, Kantartzis S, Siamouli M et al. Peripheral thyroid dysfunction in depression. World J Biol Psychiatry 2006; 7: 131-137.
32. Fraser SA, Kroenke K, Callahan CM et al. Low yield of thyroid-stimulating hormone testing in elderly patients with depression. Gen Hosp Psychiatry 2004; 26: 302-309.
33. Frude N. Understanding abnormal psychology. Oxford: Blackwell 1998.
34. Geffken GR, Ward HE, Staab JP et al. Psychiatric morbidity in endocrine disorders. Psychiatr Clin North Am 1998; 21: 473-489.
35. Gershenfeld HK, Philibert RA, Boehm GW. Looking forward in geriatric anxiety and depression. Implications of basic science for the future. Am J Geriatr Psychiatry 2005; 13: 1027-1040.
36. Glinoer D. The systematic screening and management of hypothyroidism and hyperthyroidism during pregnancy. Trends Endocrinol Metab 1998; 9: 403-411.
37. Goldberg D, Hillier V. A scaled version of the General Health Questionnaire. Psych Med 1979; 9: 139-145.
38. Graves RJ. Clinical lectures, delivered by Robert J. Graves at the Meath Hospital during the session of 1834-35: Lecture XII: Newly observed affections of the thyroid gland in females-its connections with palpitation and with fits of hysteria. Medical Classics 1940; 5: 25 ff, In: Schilddrüse: Pionierarbeiten aus eineinhalb Jahrhunderten. Hrsg. Henning, Berlin 1987.
39. Grozinsky-Glasberg S, Fraser A, Nahshoni E et al. Thyroxine- triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2006; 91: 2592-2599.
40. Grüters A, Liesenkötter KP, Zapico M et al. Results of the screening program for congenital hypothyroidism in Berlin. Exp Clin Endocrinol Diabetes 1997; 105 (Suppl 4): 28-31.
41. Gussekloo J, van Exel E, de Craen AJM et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292: 2591-2599.
42. Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid defiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-555.
43. Haggerty JJ Jr, Stern RA, Mason GA et al. Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry 1993; 150: 508-510.
44. Hautzinger M, Bailer M, Worrall H et al. Das Beck Depressionsinventar. Bern: Huber 1995.
45. Herrmann C, Buss U, Snaith RP. Hospital Anxiety and Depression Scale - deutsche Version (HADS-D). Bern: Huber 1995.
46. Höpfner S, Höpfner B, Rauterberg EW. Neonatal screening for congenital hypothyroidism in Hessen, Germany: efficiency of the screening program and school achievement of 129 children at an age of 8-12 years. J Perinat Med 2005; 33: 543-548.
47. Hutto B. Subtle psychiatric presentations of endocrine diseases. Psychiatr Clin North Am 1998; 21: 905-916.
48. Joffe RT, Nobrega JN, Kish SJ et al. Regional thyroid hormone levels in rat brain. Psychneuroendocrinol 1994; 19: 773-777.
49. Joffe RT. Is the thyroid still important in major depression. J Psychiatry Neurosci 2006; 31: 367-368.
50. Kalmijn S, Mehta KM, Pols HA et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 2000; 53: 733-737.
51. Kendall EC. Transactions of the Association of American Physicians, Philadelphia 1915; 30: 420ff. In: Schilddrüse: Pionierarbeiten aus eineinhalb Jahrhunderten. Hrsg. Henning, Berlin 1987.
52. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
53. Kobe C, Eschner W, Sudbrock F et al. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy? Nuklearmedizin 2008; 47: 13-17.
54. Kobe C, Weber I, Eschner W et al. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication? Nuklearmedizin 2008; 47: 153-166.
55. Kocher ET. Ueber Kropfextirpation und ihre Folgen. Vortrag, gehalten am 1. Sitzungstage des XII. Congresses der Dt. Ges. für Chirurgie, Berlin, 4. April 1883. Archiv für klinische Chirurgie 1883, In: Schilddrüse: Pionierarbeiten aus eineinhalb Jahrhunderten. Hrsg. Henning, Berlin 1987.
56. Kooistra L, Crawford S, van Baar AL et al. Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics 2006; 117: 161-167.
57. Larisch R, Kley K, Nikolaus S et al. Depression and anxiety in different thyroid function states. Horm Metab Res 2004 ; 36: 650-653.
58. Lederbogen F, Hermann D, Hewer W et al. Thyroid function test abnormalities in newly admitted psychiatric patients residing in an iodine-deficient area: patterns and clinical significance. Acta Psychiatr Scand 2001; 104: 305-310.
59. Lee S, Chow CC, Wing YK et al. Thyroid abnormalities during chronic lithium treatment in Hong Kong chinese: acontrolled study. J Affect Disord 1992; 26: 173-178.
60. Lojko D, Rybakowski JK. L-thyroxine augmentation of serotonergic anti-depressants in female patients with refractory depression. J Affect Disord 2007; 103: 253-256.
61. Madhusoodanan S, Brenner R, Bavli S et al. Thyroid function screening in acute geropsychiatric admissions.Ann Clin Psychiatry 2000; 12: 83-88.
62. Maes M, Meltzer HY, Cosyns P et al. An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study. Psychoneuroendocrinology 1993; 18: 607-620.
63. Mann JJ. The medical management of depression. N Engl J Med 2005; 353: 1819-1834.
64. Mc Carthy D. Manual for the Mc Carthy Scales of Children's abilities. New York: Psychological Corp 1972.
65. Meier C, Christ-Crain M, Keller U et al. Psychische Veränderungen bei Hypo- und Hyperthyreosen. Dtsch Med Wochenschr 2002; 127: 1145-1150.
66. Meier C, Staub JJ, Roth CB et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001; 86: 4860-4866.
67. Monzani F, Del Guerra P, Caraccio N et al. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig 1993; 71: 367-371.
68. Narrow WE, Rae DS, Robins LN et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002; 59: 115-123.
69. Negro R, Formoso G, Mangieri T et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91: 2587-2591.
70. Nemeroff CB. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. J Clin Psychiatry 1989; 50 (5, Suppl): 13-20.
71. No Author listed. Thyroid deficiency and mental health. Harv Ment Health Lett 2007; 23: 4-5.
72. Nyström E, Caidahl K, Fager G et al. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf) 1988; 29: 63-75.
73. Oliver C, Eskay RL, Ben-Jonathan N et al. Distribution and concentration of TRH in the rat brain. Endocrinology 1974; 95: 540-546.
74. Ordas DM, Labbate LA. Routine screening of thyroid function in patients hospitalized for major depression or dysthymia? Ann Clin Psychiatry 1995; 7: 161-165.
75. Patten SB, Williams JVB, Esposito E et al. Self-reported thyroid disease and mental disorder prevalence in the general population. Gen Hosp Psychiatry 2006; 28: 503-508.
76. Perrild H, Hegedüs L, Baastrup PC et al. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am J Psychiatr 1990; 147: 1518-1521.
77. Pop VJ, Kuijpens JL, van Baar AL et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999; 50: 149-155.
78. Prange AJ. Novel uses of thyroid hormones in patients with affective disorders. Thyroid 1996; 6: 537-543.
79. Prange AJ. Psychoneuroendocrinology - A commentary. Psychiatr Clin North Am 1998; 21: 491-505.
80. Premachandra BN, Kabir MA, Williams IK. Low T3 syndrome in psychiatric depression. J Endocrinol Invest 2006; 29: 568-572.
81. Reiners C, Wegscheider K, Schicha H et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96278 unselected employees. Thyroid 2004; 14: 926-932.
82. Roberts LM, Pattison H, Roalfe A et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction. Ann Intern Med 2006; 145: 573-581.
83. Ryan WG, Roddam RF, Grizzle WE. Thyroid function screening in newly admitted psychiatric inpatients. Ann Clin Psychiatry 1994; 6: 7-12.
84. Schmidt M, Gorbauch E, Dietlein M et al. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease. Thyroid 2006; 16: 281-288.
85. Schreckenberger MF, Egle UT, Drecker S et al. Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J Clin Endocrinol Metab 2006; 91: 4786-4791.
86. Shibusawa N, Hashimoto K,Yamada M. Thyrotropin-releasing hormone (TRH) in the cerebellum. Cerebellum 2007; DOI 10.1080/14734220701561357.
87. Surks MI, Sievert R. Drugs and thyroid function. New Engl J Med 1995; 333: 1688-1694.
88. Sun Y, Lu X, Gershengorn MC. Thyrotropin-releasing hormone receptors - similarities and differences. J Mol Endocrinol 2003; 30: 87-97.
89. Suzuki T, Abe T. Thyroid hormone transporters in the brain. Cerebellum 2007; DOI 10.1080/14734220701509851..
90. Taylor JW. Depression in thyrotoxicosis. Am J Psychiatry 1975; 132: 552-553.
91. Utiger RD. Maternal hypothyroidism and fetal development. N Engl J Med 1999; 341: 601-602.
92. Vaidya B, Anthony S, Bilous M et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007; 92: 203-207.
93. Von Basedow CA. Exophthalmos durch Hypertrophie des Zellgewebes in der Augenhöhle. Wochenschrift für die gesamte Heilkunde 1840. In: Schilddrüse: Pionierarbeiten aus eineinhalb Jahrhunderten. Hrsg. Henning, Berlin 1987.
94. Wenzel KW. Einfluss von pharmakologischen Substanzen auf die In-vitro-Tests der Schilddrüsenfunktionsdiagnostik: Anlaß zu diagnostischen Irrtümern. Therapiewoche 1980; 30: 6348-6365.
95. Wenzel KW. Schilddrüsenfunktionstests und Medikamente. Münchener Med Wochenschr 1996; 138: 658-661.
96. Wittchen HU, Zaudig M, Fydrich T. SKID. Strukturiertes Klinisches Interview für DSM-Iv. Achse I und II. Göttingen: Hogrefe 1997.
97. World Health Organization. Tenth Revision of the International Classification of Disease, Chapter V (F): Mental and Behavioural Disorders. Geneva: WHO 1992.